Zobrazeno 1 - 10
of 8 775
pro vyhledávání: '"AEs, adverse events"'
Autor:
Sconza, Cristiano1,2 (AUTHOR) cristiano.sconza@humanitas.it, Romano, Dario1 (AUTHOR), Scaturro, Dalila3 (AUTHOR), Mauro, Giulia Letizia3 (AUTHOR), Leonardi, Giulia4 (AUTHOR), Alito, Angelo5 (AUTHOR), Respizzi, Stefano1 (AUTHOR), Kon, Elizaveta1,6 (AUTHOR), Di Matteo, Berardo1,6 (AUTHOR)
Publikováno v:
Rheumatology & Therapy. Apr2024, Vol. 11 Issue 2, p381-395. 15p.
Autor:
Giga, Vojislav1,2 (AUTHOR) belkan87@gmail.com, Boskovic, Nikola1 (AUTHOR) skali.ana7@gmail.com, Djordjevic-Dikic, Ana1,2 (AUTHOR) branko.beleslin@gmail.com, Beleslin, Branko1,2 (AUTHOR) ivannanedeljkovic@yahoo.com, Nedeljkovic, Ivana1,2 (AUTHOR) gorastan@gmail.com, Stankovic, Goran1,2 (AUTHOR) misa.tesic@gmail.com, Tesic, Milorad1 (AUTHOR) ivana170679@gmail.com, Jovanovic, Ivana1 (AUTHOR) ina.paunovic@gmail.com, Paunovic, Ivana1 (AUTHOR) srdjanaleksandric@gmail.com, Aleksandric, Srdjan1 (AUTHOR)
Publikováno v:
Diagnostics (2075-4418). Jul2023, Vol. 13 Issue 13, p2229. 13p.
Autor:
Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert, Vincenzo Libri, Marta Boffito, David Owen, Henry Bern, Leon R. McFarlane, Jessica O'Hara, Nana-Marie Lemm, Paul McKay, Tommy Rampling, Yee Ting N. Yim, Ana Milinkovic, Cherry Kingsley, Tom Cole, Susanne Fagerbrink, Marites Aban, Maniola Tanaka, Savviz Mehdipour, Alexander Robbins, William Budd, Saul Faust, Hana Hassanin, Catherine A. Cosgrove, Alan Winston, Sarah Fidler, David Dunn, Sheena McCormack, Robin J. Shattock, Kirsty Adams, Fahimah Amini, Nafisah B Atako, Amalina Bakri, Wendy Barclay, Elizabeth Brodnicki, Jonathan C Brown, Ruth Byrne, Rowena Chilvers, Sofia Coelho, Suzanne Day, Monica Desai, Eleanor Dorman, Tamara Elliott, Katie E Flight, James Fletcher, John Galang, Jagruti Gohil, Aneta Gupta, Chris Harlow, Kai Hu, Mohini Kalyan, Dominic Lagrue, Ely Liscano, Cecilia Njenga, Krunal Polra, Derecia A Powlette, Paul Randell, Mary Rauchenberger, Ianto Redknap, Maravic Ricamara, Paul Rogers, Hadijatou Sallah, Karnyart Samnuan, Michael Schumacher, Zareena Shah, Rachel Shaw, Thomas Shaw, Stefan Sivapatham, Susie Slater, Kim Sorley, Regina Storch, Elizabeth Tan, Tricia Tan, Lieze Thielemans, Sarah Whitely, Charlotte Valentine, Jeeva Varghese, Asha Vikraman, Martin Wilkins
Publikováno v:
EClinicalMedicine, Vol 44, Iss, Pp 101262-(2022)
EClinicalMedicine
EClinicalMedicine
Summary: Lipid nanoparticle (LNP) encapsulated self-amplifying RNA (saRNA) is a novel technology formulated as a low dose vaccine against COVID-19. Methods: A phase I first-in-human dose-ranging trial of a saRNA COVID-19 vaccine candidate LNP-nCoVsaR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28acc41920bce70d4d6595fa69b972ce
https://eprints.soton.ac.uk/455190/
https://eprints.soton.ac.uk/455190/
Autor:
Cassandra Herman, Hui-Ju Young, Byron Lai, James H. Rimmer, Tapan Mehta, Navneet Kaur Baidwan
Publikováno v:
Archives of Rehabilitation Research and Clinical Translation
Archives of Rehabilitation Research and Clinical Translation, Vol 3, Iss 4, Pp 100160-(2021)
Archives of Rehabilitation Research and Clinical Translation, Vol 3, Iss 4, Pp 100160-(2021)
Objective: To investigate the effects of a 12-week movement-to-music (M2M) intervention on physical and psychosocial outcomes in people poststroke. Design: Two-arm randomized controlled trial. Setting: A community-based fitness facility. Participants
Publikováno v:
Translational Oncology
Translational Oncology, Vol 14, Iss 12, Pp 101238-(2021)
Translational Oncology, Vol 14, Iss 12, Pp 101238-(2021)
Highlights • Sorafenib in combination with TACE can prolong survival in patients with hepatocellular carcinoma. • Compared with TACE + placebo / alone, the combination of TACE and sorafenib can significantly improve the efficacy and safety of hep
Autor:
Firdausi Qadri, Marjahan Akhtar, Nicole Maier, Tasnuva Ahmed, Ann-Mari Svennerholm, Tanzeem Ahmed Rafique, Joanna Kaim, Anna Lundgren, Nils Carlin, Farhana Khanam, A. Louis Bourgeois, Mohiul I. Chowdhury, Arifuzzaman Khan, Yasmin Ara Begum, Alan Fix, Thomas F. Wierzba, Taufiqur Rahman Bhuiyan, Richard I. Walker, Mir Z. Sharif, Laila N. Islam, Sadia Isfat Ara Rahman
Publikováno v:
Vaccine
Highlights • The killed oral ETEC vaccine ETVAX ± dmLT adjuvant was safe in Bangladeshi adults. • All vaccinees responded to all 5 primary vaccine antigens in ALS specimens. • A majority of vaccinees responded to ≥4 antigens in plasma specim
Autor:
Bocanegra Rivera, Juan Carlos1, Gómez Buitrago, Luz María2 lm.gomez@scare.org.co, Sánchez Bello, Nubia Fernanda3, Chaves Vega, Alexandra1
Publikováno v:
Colombian Journal of Anesthesiology / Revista Colombiana de Anestesiología. Jan-Mar2023, Vol. 51 Issue 1, p1-9. 9p.
Autor:
Kari C. Nadeau, Theresa Dunham, R. Sharon Chinthrajah, Sharad Chandra, Shu Cao, Sayantani B. Sindher, Meng Chen, Vanitha Sampath
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100455-(2020)
The World Allergy Organization Journal
The World Allergy Organization Journal
Food allergy (FA) is a growing public health problem with personal, social, nutritional, and economic consequences. In the United States, it is estimated that 8% of children and 10.8% of adults have food allergies. Allergies to peanuts are particular
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100601-(2020)
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100601-(2020)
Background: Hepatitis B virus (HBV) infection is an important etiology for chronic hepatitis globally, and especially so in China. HBV infection can lead to the development of cirrhosis through the pathological process of liver fibrosis. The effectiv
Autor:
Koji Iinuma, Takuya Koie, Shigeaki Yokoi, Yuka Muramatsu Maekawa, Manabu Takai, Tomohiro Tsuchiya, Daiki Kato, Keita Nakane
Publikováno v:
Urology Case Reports
Urology Case Reports, Vol 31, Iss, Pp-(2020)
Urology Case Reports, Vol 31, Iss, Pp-(2020)
We report a fatal case of pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer. A 77-year-old man was aware of eye ptosis and diplopia after three weeks from first infusion of pembrolizumab, an anti-prog